Home › Funds › PERKINS CAPITAL MANAGEMENT INC › GILD

PERKINS CAPITAL MANAGEMENT INC position in GILD

GILEAD SCIENCES INC · Health Care

PERKINS CAPITAL MANAGEMENT INC reported holding 7,216 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$1.1M, representing 0.77% of its reported portfolio and ranking #35 among its reported holdings. PERKINS CAPITAL MANAGEMENT INC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)7.22K sh
Reported value held$1.08M
Portfolio Weight0.77%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How PERKINS CAPITAL MANAGEMENT INC's GILD position evolved

PERKINS CAPITAL MANAGEMENT INC first disclosed a stake in GILD in Q3 2023 at 13,583 shares (US$1.0M). The position peaked in Q1 2025 at 10,333 shares, worth US$1.2M. Across 13 filings, PERKINS CAPITAL MANAGEMENT INC increased the stake 0 time(s), trimmed it 8 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 7,216 shares valued at US$1.1M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 13.58K $1.02M New
Q4 2023 12.98K $1.05M Reduce
Q1 2024 12.93K $947.00K Hold
Q2 2024 12.43K $853.00K Reduce
Q3 2024 10.93K $916.62K Reduce
Q4 2024 10.83K $1.00M Reduce
Q1 2025 10.33K $1.16M Reduce
Q2 2025 8.33K $923.88K Reduce
Q3 2025 8.27K $917.53K Reduce
Q4 2025 8.27K $1.01M Hold
Q1 2026 7.22K $1.01M Reduce
Q2 2026 7.22K $911.67K Hold
Q3 2026 7.22K $1.08M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has PERKINS CAPITAL MANAGEMENT INC held GILD?

PERKINS CAPITAL MANAGEMENT INC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is PERKINS CAPITAL MANAGEMENT INC's current position in GILD?

As of Q3 2026, PERKINS CAPITAL MANAGEMENT INC holds 7.22K shares of GILD (GILEAD SCIENCES INC), valued at $1.08M, representing 0.77% of its reported portfolio and ranking #35.

Has PERKINS CAPITAL MANAGEMENT INC been buying or selling GILD?

In the latest 13F filing (Q3 2026), PERKINS CAPITAL MANAGEMENT INC held unchanged its position in GILD. The position peaked in Q1 2025 at 10.33K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.